JUN 8, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Risedronate Sodium (Labeling)
U.S. Food and Drug Administration
FDA supplemental labeling approval for generic risedronate sodium; regulatory action does not contain clinical efficacy data.
Reported
Approval date2026-06-08
ANDA application numberANDA200296
Submission classLabeling